Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency department
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1878-7657
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency department ; day:20 ; month:6 ; year:2022 ; pages:1-9
European geriatric medicine ; (20.6.2022), 1-9
- Urheber
-
Dam, Carmen S. van
Labuschagne, Helena A.
Keulen, Kris van
Kramers, Cornelis
Kleipool, Emma E.
Hoogendijk, Emiel O.
Knol, Wilma
Nanayakkara, Prabath W. B.
Muller, Majon
Trappenburg, Marijke C.
Peters, Mike J. L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s41999-022-00664-y
- URN
-
urn:nbn:de:101:1-2022081309490364517849
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dam, Carmen S. van
- Labuschagne, Helena A.
- Keulen, Kris van
- Kramers, Cornelis
- Kleipool, Emma E.
- Hoogendijk, Emiel O.
- Knol, Wilma
- Nanayakkara, Prabath W. B.
- Muller, Majon
- Trappenburg, Marijke C.
- Peters, Mike J. L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia
Effect of Comorbidity Burden and Polypharmacy on Poor Functional Outcome in Acute Ischemic Stroke
Effect modification of polypharmacy on incident frailty by chronic kidney disease in older adults
Frailty and Potentially Inappropriate Prescribing in Older People with Polypharmacy: A Bi-Directional Relationship?
Co-morbidity and polypharmacy in Parkinson’s disease: insights from a large Scottish primary care database
Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
Influence of frailty and its interaction with comorbidity on outcomes among total joint replacement
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Technologies for frailty, comorbidity, and multimorbidity in older adults: a systematic review of research designs
Correction: Influence of frailty and its interaction with comorbidity on outcomes among total joint replacement
Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients
Correction to: Technologies for frailty, comorbidity, and multimorbidity in older adults: a systematic review of research designs
Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia
Effect of Comorbidity Burden and Polypharmacy on Poor Functional Outcome in Acute Ischemic Stroke
Effect modification of polypharmacy on incident frailty by chronic kidney disease in older adults
Frailty and Potentially Inappropriate Prescribing in Older People with Polypharmacy: A Bi-Directional Relationship?
Co-morbidity and polypharmacy in Parkinson’s disease: insights from a large Scottish primary care database
Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
Influence of frailty and its interaction with comorbidity on outcomes among total joint replacement
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Technologies for frailty, comorbidity, and multimorbidity in older adults: a systematic review of research designs
Correction: Influence of frailty and its interaction with comorbidity on outcomes among total joint replacement
Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients
Correction to: Technologies for frailty, comorbidity, and multimorbidity in older adults: a systematic review of research designs
Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia
Effect of Comorbidity Burden and Polypharmacy on Poor Functional Outcome in Acute Ischemic Stroke
Effect modification of polypharmacy on incident frailty by chronic kidney disease in older adults
Frailty and Potentially Inappropriate Prescribing in Older People with Polypharmacy: A Bi-Directional Relationship?
Co-morbidity and polypharmacy in Parkinson’s disease: insights from a large Scottish primary care database
Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
Influence of frailty and its interaction with comorbidity on outcomes among total joint replacement
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Technologies for frailty, comorbidity, and multimorbidity in older adults: a systematic review of research designs
Correction: Influence of frailty and its interaction with comorbidity on outcomes among total joint replacement
Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients